PMC:7144273 / 38977-39549
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T336","span":{"begin":153,"end":158},"obj":"Body_part"},{"id":"T337","span":{"begin":167,"end":177},"obj":"Body_part"},{"id":"T338","span":{"begin":172,"end":177},"obj":"Body_part"},{"id":"T339","span":{"begin":407,"end":412},"obj":"Body_part"},{"id":"T340","span":{"begin":459,"end":464},"obj":"Body_part"}],"attributes":[{"id":"A336","pred":"fma_id","subj":"T336","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A337","pred":"fma_id","subj":"T337","obj":"http://purl.org/sig/ont/fma/fma63368"},{"id":"A338","pred":"fma_id","subj":"T338","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A339","pred":"fma_id","subj":"T339","obj":"http://purl.org/sig/ont/fma/fma7197"},{"id":"A340","pred":"fma_id","subj":"T340","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":"3 07-02-2020; 15-01-2020 to 31-12-2022 0Recruiting ChiCTR2000029606;http://www.chictr.org.cn/showproj.aspx?proj=49146 Clinical study for human menstrual blood-derived stem cells in the treatment of acute novel coronavirus pneumonia (COVID-19) MenSCs 63 Experimental group A:Conventional treatment followed by i.v. infusion of MenSCsControl group A: conventional treatmentExperimental group B:1: Artificial liver therapy + conventional treatment2: Artificial liver therapy followed by i.v. infusion of MenSCs + conventional treatmentControl group B: conventional treatment"}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T117","span":{"begin":153,"end":158},"obj":"Body_part"},{"id":"T118","span":{"begin":407,"end":412},"obj":"Body_part"},{"id":"T119","span":{"begin":459,"end":464},"obj":"Body_part"}],"attributes":[{"id":"A117","pred":"uberon_id","subj":"T117","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A118","pred":"uberon_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"A119","pred":"uberon_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":"3 07-02-2020; 15-01-2020 to 31-12-2022 0Recruiting ChiCTR2000029606;http://www.chictr.org.cn/showproj.aspx?proj=49146 Clinical study for human menstrual blood-derived stem cells in the treatment of acute novel coronavirus pneumonia (COVID-19) MenSCs 63 Experimental group A:Conventional treatment followed by i.v. infusion of MenSCsControl group A: conventional treatmentExperimental group B:1: Artificial liver therapy + conventional treatment2: Artificial liver therapy followed by i.v. infusion of MenSCs + conventional treatmentControl group B: conventional treatment"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T270","span":{"begin":222,"end":231},"obj":"Disease"},{"id":"T271","span":{"begin":233,"end":241},"obj":"Disease"}],"attributes":[{"id":"A270","pred":"mondo_id","subj":"T270","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A271","pred":"mondo_id","subj":"T271","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"3 07-02-2020; 15-01-2020 to 31-12-2022 0Recruiting ChiCTR2000029606;http://www.chictr.org.cn/showproj.aspx?proj=49146 Clinical study for human menstrual blood-derived stem cells in the treatment of acute novel coronavirus pneumonia (COVID-19) MenSCs 63 Experimental group A:Conventional treatment followed by i.v. infusion of MenSCsControl group A: conventional treatmentExperimental group B:1: Artificial liver therapy + conventional treatment2: Artificial liver therapy followed by i.v. infusion of MenSCs + conventional treatmentControl group B: conventional treatment"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T549","span":{"begin":137,"end":142},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T550","span":{"begin":153,"end":158},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T551","span":{"begin":153,"end":158},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T552","span":{"begin":167,"end":177},"obj":"http://purl.obolibrary.org/obo/CL_0000034"},{"id":"T553","span":{"begin":347,"end":348},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T554","span":{"begin":391,"end":392},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T555","span":{"begin":407,"end":412},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T556","span":{"begin":407,"end":412},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T557","span":{"begin":459,"end":464},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T558","span":{"begin":459,"end":464},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T559","span":{"begin":547,"end":548},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"}],"text":"3 07-02-2020; 15-01-2020 to 31-12-2022 0Recruiting ChiCTR2000029606;http://www.chictr.org.cn/showproj.aspx?proj=49146 Clinical study for human menstrual blood-derived stem cells in the treatment of acute novel coronavirus pneumonia (COVID-19) MenSCs 63 Experimental group A:Conventional treatment followed by i.v. infusion of MenSCsControl group A: conventional treatmentExperimental group B:1: Artificial liver therapy + conventional treatment2: Artificial liver therapy followed by i.v. infusion of MenSCs + conventional treatmentControl group B: conventional treatment"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T179","span":{"begin":266,"end":271},"obj":"Chemical"},{"id":"T180","span":{"begin":341,"end":346},"obj":"Chemical"},{"id":"T181","span":{"begin":385,"end":390},"obj":"Chemical"},{"id":"T182","span":{"begin":541,"end":546},"obj":"Chemical"}],"attributes":[{"id":"A179","pred":"chebi_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A180","pred":"chebi_id","subj":"T180","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A181","pred":"chebi_id","subj":"T181","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A182","pred":"chebi_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"3 07-02-2020; 15-01-2020 to 31-12-2022 0Recruiting ChiCTR2000029606;http://www.chictr.org.cn/showproj.aspx?proj=49146 Clinical study for human menstrual blood-derived stem cells in the treatment of acute novel coronavirus pneumonia (COVID-19) MenSCs 63 Experimental group A:Conventional treatment followed by i.v. infusion of MenSCsControl group A: conventional treatmentExperimental group B:1: Artificial liver therapy + conventional treatment2: Artificial liver therapy followed by i.v. infusion of MenSCs + conventional treatmentControl group B: conventional treatment"}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T51","span":{"begin":222,"end":231},"obj":"Phenotype"}],"attributes":[{"id":"A51","pred":"hp_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"3 07-02-2020; 15-01-2020 to 31-12-2022 0Recruiting ChiCTR2000029606;http://www.chictr.org.cn/showproj.aspx?proj=49146 Clinical study for human menstrual blood-derived stem cells in the treatment of acute novel coronavirus pneumonia (COVID-19) MenSCs 63 Experimental group A:Conventional treatment followed by i.v. infusion of MenSCsControl group A: conventional treatmentExperimental group B:1: Artificial liver therapy + conventional treatment2: Artificial liver therapy followed by i.v. infusion of MenSCs + conventional treatmentControl group B: conventional treatment"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T178","span":{"begin":0,"end":395},"obj":"Sentence"},{"id":"T179","span":{"begin":396,"end":447},"obj":"Sentence"},{"id":"T180","span":{"begin":448,"end":572},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"3 07-02-2020; 15-01-2020 to 31-12-2022 0Recruiting ChiCTR2000029606;http://www.chictr.org.cn/showproj.aspx?proj=49146 Clinical study for human menstrual blood-derived stem cells in the treatment of acute novel coronavirus pneumonia (COVID-19) MenSCs 63 Experimental group A:Conventional treatment followed by i.v. infusion of MenSCsControl group A: conventional treatmentExperimental group B:1: Artificial liver therapy + conventional treatment2: Artificial liver therapy followed by i.v. infusion of MenSCs + conventional treatmentControl group B: conventional treatment"}